<?xml version="1.0" encoding="UTF-8"?>
<p>Rapid and accurate detection of SARS‐CoV‐2‐specific antibodies in the blood of patients is one of the options for supplemental nucleic acid testing. IgM provides the first line of defence during viral infection, followed by the production of IgG that is important for long‐term immunity and immunological memory.
 <xref rid="jcmm15364-bib-0068" ref-type="ref">
  <sup>68</sup>
 </xref> Moreover, positive IgM antibody often indicates an acute phase of infection while positive IgG antibody indicates late or previous infection. Therefore, we believe that detection of IgM and IgG can also provide information on the time course of virus infection. However, since serological test was gradually established, its diagnostic function was only recognized in ‘Diagnosis and Treatment Guideline of the Novel Coronavirus Pneumonia (Version 7)’ of China (Table 
 <xref rid="jcmm15364-tbl-0001" ref-type="table">1</xref>).
</p>
